Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients

Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients

Saved in:

Bibliographic Details
Main Authors:	Edmund Chiong, Ziteng Wang, Eleanor Jing Yi Cheong, Yi Chen Yao, Sin Mun Tham, Revathi Periaswami, Poh Choo Toh, Ziting Wang, Qing Hui Wu, Woon Chau Tsang, Arshvin Kesavan, Alvin Seng Cheong Wong, Patrick Thomas Wong, Felicia Lim, Shuaibing Liu, Eric Chun Yong Chan
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	Cancer Communications
Online Access:	https://doi.org/10.1002/cac2.70035
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic factors for patients treated with abiraterone
by: Cecília M Alvim, et al.
Published: (2020-02-01)

Oral mucositis with abiraterone acetate: A therapeutic dilemma
by: Shaunak Valame, et al.
Published: (2020-01-01)

Prescription pattern of abiraterone in Brazil - a survey of medical oncologists
by: João Pedro Homse-Netto, et al.
Published: (2023-08-01)

Case Report: Abiraterone in brain metastases from prostate cancer
by: Tobias Peres, et al.
Published: (2025-04-01)

Abiraterone and Galeterone, Powerful Tools Against Prostate Cancer: Present and Perspective
by: Ivana Z. Kuzminac, et al.
Published: (2024-10-01)

Retraction: Targeted non AR mediated smart delivery of abiraterone to the prostate cancer.
by: PLOS One Editors
Published: (2025-01-01)

Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
by: Eva Streckova, et al.
Published: (2025-01-01)

Serious Hypokalemia Associated with Abiraterone Acetate in Patients with Castration-Resistant Prostate Cancer
by: Yutaka Yamamoto, et al.
Published: (2018-01-01)

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in "hormone refractory prostate cancer"
by: Arun Kumar Goel, et al.
Published: (2011-01-01)

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
by: Xiaolin Lu, et al.
Published: (2025-05-01)

A pilot clinical study of developing an External Assist Targeting Device for rapid and precise renal calyx access during percutaneous nephrolithotomy
by: Qinghui Wu, et al.
Published: (2023-07-01)

Correction: Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-08-01)

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-03-01)

Brasil 500 pássaros
by: Martine Droulers
Published: (2000-07-01)

Short-term efficacy of enzalutamide in treatment of patients with abiraterone-resistant metastatic castration-resistant prostate cancer
by: MEI Jingchang, SU Xiaonan, YAO Yu, GUAN Fengju, ZHANG Guiming
Published: (2025-02-01)

Prognostic value of prostate-specific antigen in advanced prostate cancer treated with androgen deprivation therapy and abiraterone
by: L. Lou, et al.
Published: (2024-11-01)

mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases
by: Brandon E. K. Tan, et al.
Published: (2025-07-01)

Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue
by: Brandon E. K. Tan, et al.
Published: (2025-05-01)

More than 1,001 problems with protein domain databases: transmembrane regions, signal peptides and the issue of sequence homology.
by: Wing-Cheong Wong, et al.
Published: (2010-07-01)

Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis
by: Sharath Kumar, et al.
Published: (2025-08-01)

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2019-01-01)

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
by: Hakan Taban, et al.
Published: (2025-06-01)

The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Metastatic Castrate-Sensitive Prostate Cancer Patients Treated with Abiraterone Acetate
by: Caio Vinícius Suartz, et al.
Published: (2024-08-01)

A Super‐Enhancer‐Driven Transcriptional Regulatory Circuit Underlying Abiraterone Resistance in Castration‐Resistant Prostate Cancer
by: Liling Jiang, et al.
Published: (2025-08-01)

Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients
by: N. K. Mazina, et al.
Published: (2017-11-01)

Exploring the perspectives of child health strategy stakeholders on resilience and well-being in children and youths in Singapore: A qualitative study
by: Yee Keow Chiong, et al.
Published: (2025-01-01)

Suppression of Aedes aegypti may not affect sympatric Aedes albopictus populations: findings from two years of entomological surveillance in Singapore
by: Wei Jian Wong, et al.
Published: (2025-01-01)

Design of a 500w Inverter.
by: Kyomuhendo Medius
Published: (2023)

Flood injustice in 500-year floodplains
by: Ali Farshid, et al.
Published: (2025-04-01)

Severe Late-Onset Abiraterone-Induced Hypokalemia in a Diabetic Patient With Concomitant Adrenal Gland Incidentaloma: A Diagnostic Challenge
by: Andrea Tumminia, et al.
Published: (2025-01-01)

A novel RP-HPLC stability-indicating method for simultaneous estimation of Niraparib and Abiraterone in synthetic mixtures and combined tablet formulations
by: Krishnaphanisri Ponnekanti, et al.
Published: (2025-05-01)

Pathologic response as an early endpoint for survival following neoadjuvant androgen deprivation therapy plus abiraterone acetate for metastatic prostate cancer
by: Kaichen Zhou, et al.
Published: (2025-04-01)

Chondroblastoma of the Triquetrum
by: Chen-Te Wu, et al.
Published: (2013-08-01)

Launch of TAVALOXX 500mg and 750mg
by: Editorial Office
Published: (2008-02-01)

Camões, 500 anos: o tempo acorrentado
by: Alexei Bueno
Published: (2025-06-01)

500 Tips for Quality Enhancement in Universities and Colleges /
by: Sally Brown
Published: (1997)

Amplify photo-avalanche nonlinearity beyond 500
by: Yawei Liu, et al.
Published: (2025-08-01)

Search „A2, Liebesleben, 500 words“
by: Anne Raveling
Published: (2025-03-01)

500th Meeting of the Cambridge Entomological Club
Published: (1931-01-01)

Augmentatian of the Breast: A Study of 500 Cases
by: S. P. Bhatia, et al.
Published: (1977-07-01)